tradingkey.logo

Aspen Aerogels Inc

ASPN

6.710USD

+0.120+1.82%
Close 09/15, 16:00ETQuotes delayed by 15 min
551.92MMarket Cap
LossP/E TTM

Aspen Aerogels Inc

6.710

+0.120+1.82%

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated2025-09-12

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. The company is performing well in the stock market, with strong fundamentals and technicals supporting the current trend. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking
29 / 72
Overall Ranking
156 / 4724
Industry
Chemicals

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 8 analysts
Buy
Current Rating
9.583
Target Price
+45.42%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks
Aspen Aerogels, Inc. is an aerogel technology company, which provides sustainability and electrification solutions. The Company's aerogel technology enables its customers and partners to achieve their own objectives around the global megatrends of resource efficiency, e-mobility and clean energy. Its segments include Energy Industrial and Thermal Barrier. Under Energy Industrial, it designs, develops and manufactures aerogel insulation used primarily in the energy industrial and sustainable insulation markets. The Company offers two aerogel insulation product lines for the energy industrial market, Pyrogel and Cryogel. Under Thermal Barrier segment, it offers PyroThin product, which is a thermal barrier designed with other functional layers to impede the propagation of thermal runaway across multiple lithium-ion battery system architectures. Its thermal barrier technology is designed to offer a combination of thermal management, mechanical performance, and fire protection properties.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 150.99% year-on-year.
Turnaround to Profit
The company's performance has turned profitable, with the latest annual net income of USD 13.38M.%!(EXTRA int=2)
Fairly Valued
The company’s latest PB is 1.76, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 76.21M shares, decreasing 16.64% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 4.47M shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.38.

Financial Health

Currency: USD Updated2025-09-12

The company's current financial score is 7.72, which is higher than the Chemicals industry's average of 6.99. Its financial status is robust, and its operating efficiency is average. Its latest quarterly revenue reached 78.72M, representing a year-over-year decrease of 16.70%, while its net profit experienced a year-over-year decrease of 16316.84%.

Score

Industry at a Glance

Previous score
7.72
Change
0

Financials

10.00

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data

Quality of Earnings

6.60

Operational Efficiency

7.53

Growth Potential

7.36

Shareholder Returns

7.12

Company Valuation

Currency: USD Updated2025-09-12

The company’s current valuation score is 1.20, which is lower than the Chemicals industry's average of 2.55. Its current P/E ratio is -1.85, which is -10.65% below the recent high of -1.65 and -206.19% above the recent low of -5.65.

Score

Industry at a Glance

Previous score
4.00
Change
0

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 29/72
No Data

Earnings Forecast

Currency: USD Updated2025-09-12

The company’s current earnings forecast score is 7.25, which is lower than the Chemicals industry's average of 7.30. The average price target for Aspen Aerogels Inc is 9.50, with a high of 14.00 and a low of 6.00.

Score

Industry at a Glance

Previous score
7.00
Change
0

Support & Resistance

No Data

Analyst Rating

Based on 8 analysts
Buy
Current Rating
9.583
Target Price
+45.42%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

24
Total
4
Median
7
Average
Company name
Ratings
Analysts
Aspen Aerogels Inc
ASPN
8
Albemarle Corp
ALB
28
Ecolab Inc
ECL
27
Eastman Chemical Co
EMN
19
Celanese Corp
CE
18
Sociedad Quimica y Minera de Chile SA
SQM
15
1
2
3
4
5

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated2025-09-12

The company’s current price momentum score is 6.71, which is lower than the Chemicals industry's average of 8.17. Sideways: Currently, the stock price is trading between the resistance level at 9.05 and the support level at 5.72, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
6.00
Change
0.33

Support & Resistance

No Data

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(2)
Neutral(3)
Buy(1)
Indicators
Value
Direction
MACD(12,26,9)
-0.006
Sell
RSI(14)
47.543
Neutral
STOCH(KDJ)(9,3,3)
67.441
Buy
ATR(14)
0.336
High Vlolatility
CCI(14)
-13.925
Neutral
Williams %R
49.543
Neutral
TRIX(12,20)
-0.437
Sell
StochRSI(14)
89.445
Overbought
Moving Average
Sell(3)
Neutral(0)
Buy(3)
Indicators
Value
Direction
MA5
6.606
Buy
MA10
6.608
Buy
MA20
6.761
Sell
MA50
7.116
Sell
MA100
6.503
Buy
MA200
8.209
Sell

Institutional Confidence

Currency: USD Updated2025-09-12

The company’s current institutional recognition score is 10.00, which is higher than the Chemicals industry's average of 7.92. The latest institutional shareholding proportion is 92.73%, representing a quarter-over-quarter decrease of 0.88%. The largest institutional shareholder is The Vanguard, holding a total of 4.47M shares, representing 5.43% of shares outstanding, with 2.54% increase in holdings.

Score

Industry at a Glance

Previous score
10.00
Change
0

Institutional Shareholding

No Data

Shareholder Activity

Name
Shares Held
Chg %
Koch Industries LLC
12.28M
--
The Vanguard Group, Inc.
Star Investors
4.36M
+0.30%
Twin Oaks Partners
4.39M
+17.48%
BlackRock Institutional Trust Company, N.A.
4.32M
-2.69%
George Kaiser Family Foundation
3.17M
--
Needham Investment Management L.L.C.
2.74M
+14.54%
Dimensional Fund Advisors, L.P.
2.51M
+24.22%
State Street Global Advisors (US)
1.49M
+0.46%
Telemark Asset Management, LLC
1.89M
--
1
2

Risk Assessment

Currency: USD Updated2025-09-12

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Chemicals export-driven industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The company’s current risk assessment score is 2.99, which is lower than the Chemicals industry's average of 4.12. The company's beta value is 2.66. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.

Score

Industry at a Glance

Previous score
2.99
Change
0
Beta vs S&P 500 index
2.81
VaR
+6.96%
240-Day Maximum Drawdown
+84.90%
240-Day Volatility
+85.64%
Return
Best Daily Return
60 days
+11.04%
120 days
+14.85%
5 years
+56.70%
Worst Daily Return
60 days
-8.13%
120 days
-24.25%
5 years
-42.69%
Sharpe Ratio
60 days
+1.09
120 days
+0.27
5 years
+0.22
Risk Assessment
Maximum Drawdown
240 days
+84.90%
3 years
+86.41%
5 years
+93.23%
Return-to-Drawdown Ratio
240 days
-0.90
3 years
-0.17
5 years
-0.11
Skewness
240 days
-0.57
3 years
+1.95
5 years
+1.03
Volatility
Realised Volatility
240 days
+85.64%
5 years
+81.72%
Standardised True Range
240 days
+10.45%
5 years
+18.32%
Downside Risk-Adjusted Return
120 days
+37.72%
240 days
+37.72%
Maximum Daily Upside Volatility
60 days
+63.12%
Maximum Daily Downside Volatility
60 days
+45.34%
Liquidity
Average Turnover Rate
60 days
+2.42%
120 days
+2.40%
5 years
--
Turnover Deviation
20 days
+38.06%
60 days
+14.13%
120 days
+12.85%

Peer Comparison

Chemicals
Aspen Aerogels Inc
Aspen Aerogels Inc
ASPN
6.50 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Element Solutions Inc
Element Solutions Inc
ESI
7.47 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Perimeter Solutions Inc
Perimeter Solutions Inc
PRM
7.34 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Ingevity Corp
Ingevity Corp
NGVT
7.19 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Hawkins Inc
Hawkins Inc
HWKN
7.18 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Linde PLC
Linde PLC
LIN
7.17 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI